Under the dominant model of rs660895, the baseline cross-sectional study included 429 PD patients who were divided into two HLA-DRB1 genotype groups: the G allele carriers (AG + GG) and the G allele non-carriers (AA). This evidence concerns the gene HLA-DRB1 and Parkinson disease.